Gene transfer in the lung using recombinant adeno-associated virus

Area of Science:

• * Molecular and Cellular Biology
• * Virology
• * Gene Therapy Vector Development

Background:

• * Adeno-associated virus (AAV) is a small, replication-deficient DNA virus with a single-stranded genome.
• * Recombinant AAV (rAAV) vectors are engineered by replacing viral genes with therapeutic transgenes, retaining essential inverted terminal repeats for vector function.
• * The AAV capsid, or serotype, dictates tissue tropism, crucial for targeted gene delivery.

Purpose of the Study:

• * To guide serotype selection for effective targeting of the murine lung with rAAV vectors.
• * To identify factors influencing efficient delivery of rAAV vectors to the lung.
• * To detail methodologies for rAAV delivery and subsequent tissue analysis in preclinical models.

Main Methods:

• * Review and discussion of AAV serotype characteristics relevant to lung tropism.
• * Description of established lung delivery techniques: intranasal, orotracheal, and surgical tracheal injection.
• * Outline of procedures for sample collection and post-mortem tissue processing for evaluating vector delivery and transduction.

Main Results:

• * (Implicit) Provides a framework for understanding AAV serotype tropism in the lung.
• * (Implicit) Highlights key variables affecting successful rAAV transduction in lung tissue.
• * (Implicit) Establishes standardized protocols for lung-directed AAV vector delivery and analysis.

Conclusions:

• * Strategic selection of AAV serotypes is critical for achieving efficient gene transfer to the lung.
• * Optimized delivery methods are essential for maximizing rAAV vector transduction in lung tissues.
• * Standardized protocols facilitate reproducible research in AAV-mediated lung gene therapy.